Asia Pacific Molecular Diagnostics Market Forecast to 2030

According to the research team’ research, the Asia Pacific molecular diagnostics market was valued at US$ 3,478.48 million in 2022 and is expected to reach US$ 9,698.11 million by 2030, registering a CAGR of 13.7% from 2022 to 2030. Development of new products and increase in demand for point-of-care testing and surging prevalence of associated diseases are the critical factors attributed to the Asia Pacific molecular diagnostics market expansion.

Molecular diagnostics procedures can be employed in the detection of a wide range of conditions such as oncologic diseases, infectious diseases, cardiac diseases, and immune system disorders; they can also be used in genetic testing using genetic material such as DNA and RNA for the diagnosis of different diseases. Cancer is one of the leading causes of death worldwide. The early detection of the disease can help prevent death among the patients. The World Health Organization (WHO) stated that cancer was a cause of ~70% of deaths in low- and middle-income countries in 2021. As per the Global Burden of Disease Study in the Global Health Data Exchange and the World Health Statistics 2020, cardiovascular disease (CVD) mortality in China was 322 per 100,000 population, while India reported 185 per 100,000 population of CVD. Thus, the rising prevalence of target diseases fuels the molecular diagnostics market growth.

On the contrary, limitations associated with molecular testing hurdles the growth of Asia Pacific molecular diagnostics market.

Based on disease area, the Asia Pacific molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment held 42.8% share of Asia Pacific molecular diagnostics market in 2022, amassing US$ 1,488.15 million. It is projected to garner US$ 4,230.37 million by 2030 to expand at 14.0% CAGR during 2022–2030.

Based on technology, the Asia Pacific molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment held 48.5% share of Asia Pacific molecular diagnostics market in 2022, amassing US$ 1,685.74 million. It is projected to garner US$ 4,869.94 million by 2030 to expand at 14.2% CAGR during 2022–2030. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the Asia Pacific molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment held 65.9% share of Asia Pacific molecular diagnostics market in 2022, amassing US$ 2,291.67 million. It is projected to garner US$ 6,576.69 million by 2030 to expand at 14.1% CAGR during 2022–2030.

Based on end users, the Asia Pacific molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held 41.4% share of Asia Pacific molecular diagnostics market in 2022, amassing US$ 1,441.00 million. It is projected to garner US$ 4,130.95 million by 2030 to expand at 14.1% CAGR during 2022–2030.

Based on country, the Asia Pacific molecular diagnostics market has been categorized into the India, Singapore, Malaysia, the Philippines, Thailand, Indonesia, Vietnam, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 22.8% share of Asia Pacific molecular diagnostics market in 2022. It was assessed at US$ 792.71 million in 2022 and is likely to hit US$ 2,356.74 million by 2030, exhibiting a CAGR of 14.6% during 2022–2030.

Key players operating in the Asia Pacific molecular diagnostics market are Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited, among others.

In July 2023, Thermo Fisher launched new software for molecular diagnostics labs. This software helps in streamlining routine diagnostics testing for standardization and rapid time-to-results. It can enhance the potential of a lab to dynamically respond to quickly changing testing environments by connecting workflow steps within a single interface. In Nov 2021, Thermo Fisher Scientific Inc., the world leader in serving science, has innovative proteomics solutions and a series of co-marketing agreements with industry experts, advancing the throughput, comprehensiveness, and quality of proteomics workflows for applications such as single-cell studies and translational research.

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Molecular Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
5. Asia Pacific Molecular Diagnostics Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:
6. Molecular Diagnostics Market – Asia Pacific Market Analysis
6.1 Asia Pacific Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Disease Area
7.1 Overview
7.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
7.4.1 Overview
7.4.2 Infectious Disease: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
7.5.1 Overview
7.5.2 Genetic Testing: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
7.6.1 Overview
7.6.2 Cardiac Diseases: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
7.7.1 Overview
7.7.2 Immune System Disorders: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Technology
8.1 Overview
8.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 RT-PCR
8.3.2.1.1 Overview
8.3.3 RT-PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.3.1 qPCR
8.3.3.1.1 Overview
8.3.4 PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.4.1 Multiplex PCR
8.3.4.1.1 Overview
8.3.5 Multiplex PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.5.1 Others
8.3.5.1.1 Overview
8.3.6 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
8.5.1 Overview
8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
8.6.1 Overview
8.6.2 DNA Microarrays: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
8.7.1 Overview
8.7.2 In-Situ Hybridization (ISH): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services
9.1 Overview
9.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
9.3.1 Overview
9.3.2 Assays and Kits: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
9.4.1 Overview
9.4.2 Instruments: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
9.5.1 Overview
9.5.2 Services and Software: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
10.4.1 Overview
10.4.2 Diagnostics Laboratories: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. Asia Pacific Molecular Diagnostics Market – Country Analysis
11.1 Asia Pacific Molecular Diagnostics Market, Revenue and Forecast to 2030
11.1.1 Overview
11.1.1.1 Asia Pacific Molecular Diagnostics Market by Country
11.1.2 China
11.1.2.1 Overview
11.1.3 China: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.4 China: Molecular Diagnostics Market, by Disease Area
11.1.5 China: Molecular Diagnostics Market, by Technology
11.1.5.1 China: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.6 China:Molecular Diagnostics Market, by Product and Services
11.1.7 China: Molecular Diagnostics Market, by End User
11.1.8 Japan
11.1.8.1 Overview
11.1.9 Japan: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.10 Japan: Molecular Diagnostics Market, by Disease Area
11.1.11 Japan: Molecular Diagnostics Market, by Technology
11.1.11.1 Japan: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.12 Japan: Molecular Diagnostics Market, by Product and Services
11.1.13 Japan: Molecular Diagnostics Market, by End User
11.1.14 India
11.1.14.1 Overview
11.1.15 India: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.16 India: Molecular Diagnostics Market, by Disease Area
11.1.17 India: Molecular Diagnostics Market, by Technology
11.1.17.1 India: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.18 India: Molecular Diagnostics Market, by Product and Services
11.1.19 India: Molecular Diagnostics Market, by End User
11.1.20 Australia
11.1.20.1 Overview
11.1.21 Australia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.22 Australia: Molecular Diagnostics Market, by Disease Area
11.1.23 Australia: Molecular Diagnostics Market, by Technology
11.1.23.1 Australia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.24 Australia: Molecular Diagnostics Market, by Product and Services
11.1.25 Australia: Molecular Diagnostics Market, by End User
11.1.26 South Korea
11.1.26.1 Overview
11.1.27 South Korea: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.28 South Korea: Molecular Diagnostics Market, by Disease Area
11.1.29 South Korea: Molecular Diagnostics Market, by Technology
11.1.29.1 South Korea: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.30 South Korea: Molecular Diagnostics Market, by Product and Services
11.1.31 South Korea: Molecular Diagnostics Market, by End User
11.1.32 Singapore
11.1.32.1 Overview
11.1.33 Singapore: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.34 Singapore: Molecular Diagnostics Market, by Disease Area
11.1.35 Singapore: Molecular Diagnostics Market, by Technology
11.1.35.1 Singapore: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.36 Singapore: Molecular Diagnostics Market, by Product and Services
11.1.37 Singapore: Molecular Diagnostics Market, by End User
11.1.38 Malaysia
11.1.38.1 Overview
11.1.39 Malaysia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.40 Malaysia: Molecular Diagnostics Market, by Disease Area
11.1.41 Malaysia: Molecular Diagnostics Market, by Technology
11.1.41.1 Malaysia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.42 Malaysia: Molecular Diagnostics Market, by Product and Services
11.1.43 Malaysia: Molecular Diagnostics Market, by End User
11.1.44 Philippines
11.1.44.1 Overview
11.1.45 Philippines: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.46 Philippines: Molecular Diagnostics Market, by Disease Area
11.1.47 Philippines: Molecular Diagnostics Market, by Technology
11.1.47.1 Philippines: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.48 Philippines: Molecular Diagnostics Market, by Product and Services
11.1.49 Philippines: Molecular Diagnostics Market, by End User
11.1.50 Thailand
11.1.50.1 Overview
11.1.51 Thailand: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.52 Thailand: Molecular Diagnostics Market, by Disease Area
11.1.53 Thailand: Molecular Diagnostics Market, by Technology
11.1.53.1 Thailand: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.54 Thailand: Molecular Diagnostics Market, by Product and Services
11.1.55 Thailand: Molecular Diagnostics Market, by End User
11.1.56 Indonesia
11.1.56.1 Overview
11.1.57 Indonesia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.58 Indonesia: Molecular Diagnostics Market, by Disease Area
11.1.59 Indonesia: Molecular Diagnostics Market, by Technology
11.1.59.1 Indonesia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.60 Indonesia: Molecular Diagnostics Market, by Product and Services
11.1.61 Indonesia: Molecular Diagnostics Market, by End User
11.1.62 Vietnam
11.1.62.1 Overview
11.1.63 Vietnam: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.64 Vietnam: Molecular Diagnostics Market, by Disease Area
11.1.65 Vietnam: Molecular Diagnostics Market, by Technology
11.1.65.1 Vietnam: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.66 Vietnam: Molecular Diagnostics Market, by Product and Services
11.1.67 Vietnam: Molecular Diagnostics Market, by End User
11.1.68 Rest of Asia Pacific
11.1.68.1 Overview
11.1.69 Rest of Asia Pacific: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.70 Rest of Asia Pacific: Molecular Diagnostics Market, by Disease Area
11.1.71 Rest of Asia Pacific: Molecular Diagnostics Market, by Technology
11.1.71.1 Rest of Asia Pacific: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.72 Rest of Asia Pacific: Molecular Diagnostics Market, by Product and Services
11.1.73 Rest of Asia Pacific: Molecular Diagnostics Market, by End User
12. Asia Pacific Molecular Diagnostics Market Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Asia Pacific Molecular Diagnostics Market, Key Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Agilent Technologies Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Qiagen NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 bioMerieux SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Illumina Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Danaher
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Siemens Healthineers AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Novartis AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 TBG Diagnostics Limited
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

Table 1. Asia Pacific Molecular Diagnostics Market Segmentation
Table 2. China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 3. China:Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 4. China: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 5. China: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 6. China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 7. Japan: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Disease Area
Table 8. Japan: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Technology
Table 9. Japan: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 10. Japan: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Product and Services
Table 11. Japan: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 12. India: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 13. India: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 14. India: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 15. India: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 16. India: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 17. Australia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 18. Australia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 19. Australia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 20. Australia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 21. Australia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 22. South Korea: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 23. South Korea: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 24. South Korea: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 25. South Korea: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 26. South Korea: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 27. Singapore: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 28. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 29. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 30. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 31. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – End User
Table 32. Malaysia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 33. Malaysia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 34. Malaysia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 35. Malaysia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 36. Malaysia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 37. Philippines: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 38. Philippines: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 39. Philippines: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 40. Philippines: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 41. Philippines: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 42. Thailand: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 43. Thailand: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 44. Thailand: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 45. Thailand: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 46. Thailand: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 47. Indonesia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 48. Indonesia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 49. Indonesia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 50. Indonesia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 51. Indonesia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 52. Vietnam: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 53. Vietnam: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 54. Vietnam: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 55. Vietnam: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 56. Vietnam: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 57. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 58. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 59. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 60. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 61. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 62. Organic Developments Done By Companies
Table 63. Inorganic Developments Done By Companies
Table 64. Glossary of Terms, Molecular Diagnostics Market

Figure 1. Asia Pacific – PEST Analysis
Figure 2. Asia Pacific Molecular Diagnostics Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Asia Pacific Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
Figure 6. Oncology: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Infectious Disease: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Genetic Testing: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Cardiac Diseases: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Immune System Disorders: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 13. PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. RT-PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. qPCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Multiplex PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. DNA microarrays: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. In-Situ Hybridization (ISH): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Asia Pacific Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 24. Assays and Kits: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Instruments: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Services and Software: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Asia Pacific Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 28. Hospitals and Clinics: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Ambulatory Surgical Centers: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Research and Academic Institutes: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Asia Pacific Molecular Diagnostics Market, By Country, 2022 (US$ Mn)
Figure 33. Asia Pacific Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
Figure 34. China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 35. Japan: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. India: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 37. Australia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 38. South Korea: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 39. Singapore: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 40. Malaysia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 41. Philippines: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 42. Thailand: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 43. Indonesia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 44. Vietnam: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 45. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 46. Growth Strategies Done by the Companies in the Market (%)